| A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the … SS Lim, T Vos, AD Flaxman, G Danaei, K Shibuya, H Adair-Rohani, ... The lancet 380 (9859), 2224-2260, 2012 | 15636 | 2012 |
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11375 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10321 | 2012 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The lancet 388 (10053), 1545-1602, 2016 | 6114* | 2016 |
| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1264* | 2020 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 657 | 2021 |
| 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis PC Grayson, C Ponte, R Suppiah, JC Robson, A Craven, A Judge, ... Arthritis & Rheumatology 74 (3), 386-392, 2022 | 485* | 2022 |
| Understanding academics' adoption of learning technologies: A systematic review Q Liu, S Geertshuis, R Grainger Computers & Education 151, 103857, 2020 | 259 | 2020 |
| A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19 AHJ Kim, JA Sparks, JW Liew, MS Putman, F Berenbaum, ... Annals of internal medicine 172 (12), 819-821, 2020 | 256 | 2020 |
| Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries MA Gianfrancesco, KL Hyrich, L Gossec, A Strangfeld, L Carmona, ... The Lancet Rheumatology 2 (5), e250-e253, 2020 | 246 | 2020 |
| 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis C Ponte, PC Grayson, JC Robson, R Suppiah, KB Gribbons, A Judge, ... Annals of the Rheumatic Diseases 81 (12), 1647-1653, 2022 | 215 | 2022 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 215 | 2021 |
| Outcome domains for studies of acute and chronic gout HR Schumacher, W Taylor, L Edwards, R Grainger, N Schlesinger, ... The Journal of Rheumatology 36 (10), 2342-2345, 2009 | 153 | 2009 |
| Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ... RMD open 7 (3), e001814, 2021 | 151 | 2021 |
| Apps for people with rheumatoid arthritis to monitor their disease activity: a review of apps for best practice and quality R Grainger, H Townsley, B White, T Langlotz, WJ Taylor JMIR mHealth and uHealth 5 (2), e6956, 2017 | 150 | 2017 |
| COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations R Grainger, AHJ Kim, R Conway, J Yazdany, PC Robinson Nature Reviews Rheumatology 18 (4), 191-204, 2022 | 144 | 2022 |
| Medical management of osteoarthritis of the knee and hip joints R Grainger, FM Cicuttini Medical journal of Australia 180 (5), 232, 2004 | 136 | 2004 |
| SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 132 | 2022 |
| Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low‐dose colchicine EW Chia, R Grainger, JL Harper British journal of pharmacology 153 (6), 1288-1295, 2008 | 128 | 2008 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 115 | 2021 |
William J. TaylorAssociate Professor, Department of Medicine, University of Otago Wellington在 otago.ac.nz 的电子邮件经过验证
